- Home
- Equipment
- australasia
- urine sampling
Refine by
Urine Sampling Equipment Supplied In Australasia
6 equipment items found
Manufactured by:Pacific Edge Ltd based inDunedin,, NEW ZEALAND
Cxbladder is a non-invasive genomic urine test that quickly and accurately detects or rules out bladder cancer. The tests works at a molecular level, measuring five biomarker genes to detect the presence or absence of bladder cancer1, and comes as a suite of three product variations, each optimised for a different point in the patient ...
Manufactured by:Pacific Edge Ltd based inDunedin,, NEW ZEALAND
Cxcolorectal is a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. The test predicts the aggressiveness of the tumour, allowing physicians to make the best decision regarding treatment for the ...
Manufactured by:Macherey-Nagel GmbH & Co. KG based inDueren, GERMANY
The use of urine test strips is acknowledged as modern screening method in medical practice. With these non-invasive tests important information on the health status of the patient is rapidly obtained. The urine sample is easily drawn and can immediately be investigated with a test strip. ...
Manufactured by:INOVIQ Ltd based inNotting Hill, AUSTRALIA
INOVIQ has developed a proprietary immunocytochemistry (ICC) assay that detects hTERT, a component of telomerase, which is upregulated in most human epithelial ...
Manufactured by:SpeeDx based inSydney, AUSTRALIA
Single well qPCR test for detection of Neisseria gonorrhoeae and markers linked to ciprofloxacin susceptibility validated on a range of specimens and collection vessels. Antibiotic resistance in gonorrhoea infections is a global concern. There are limited effective treatment options and novel antibiotics are not readily available. Smarter and more directed use of antibiotics can be achieved ...
Manufactured by:SpeeDx based inSydney, AUSTRALIA
Single well qPCR test for detection of Mycoplasma genitalium (Mgen) and macrolide resistance markers validated on a range of specimens and collection vessels. Resistance to the macrolide treatment (Azithromycin) is of growing concern when managing M. genitalium (Mgen) infections. Guidelines around the world now call for the practice of Resistance Guided Therapy to guide appropriate treatment ...